<SEC-DOCUMENT>0001004878-16-000344-index.html : 20160115 <SEC-HEADER>0001004878-16-000344.hdr.sgml : 20160115 <ACCEPTANCE-DATETIME>20160115164816 ACCESSION NUMBER: 0001004878-16-000344 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20160113 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20160115 DATE AS OF CHANGE: 20160115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CEL SCI CORP CENTRAL INDEX KEY: 0000725363 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 840916344 STATE OF INCORPORATION: CO FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-11889 FILM NUMBER: 161345933 BUSINESS ADDRESS: STREET 1: 8229 BOONE BLVD . STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 BUSINESS PHONE: 7035069460 MAIL ADDRESS: STREET 1: 8229 BOONE BLVD. STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 FORMER COMPANY: FORMER CONFORMED NAME: INTERLEUKIN 2 INC DATE OF NAME CHANGE: 19880317 </SEC-HEADER> <DOCUMENT> <TYPE>8-K/A <SEQUENCE>1 <FILENAME>form8kamd101declarasale1-16.txt <DESCRIPTION>8-K AMEND RE SALE TO DE CLARA TRUST <TEXT> Document 1 - file: form8kamd101declarasale1-16.txt
</DOCUMENT> <DOCUMENT> <TYPE>EX-5 <SEQUENCE>2 <FILENAME>form8kamd101ex51-16.txt <DESCRIPTION>EXH. 5 - LEGAL OPINION <TEXT> Document 2 - file: form8kamd101ex51-16.txt
</DOCUMENT> <DOCUMENT> <TYPE>EX-10 <SEQUENCE>3 <FILENAME>form8kamd101ex10fff1-16.txt <DESCRIPTION>EXH. 10(FFF) - DE CLARA TRUST SUB AGREE <TEXT> Document 3 - file: form8kamd101ex10fff1-16.txt
</DOCUMENT> <DOCUMENT> <TYPE>EX-10 <SEQUENCE>4 <FILENAME>form8kamd101ex10ggg1-16.txt <DESCRIPTION>EXH. 10(GGG) - SERIES X WARRANT <TEXT> Document 4 - file: form8kamd101ex10ggg1-16.txt
</DOCUMENT> <DOCUMENT> <TYPE>EX-23 <SEQUENCE>5 <FILENAME>form8kamd101ex231-16.txt <DESCRIPTION>EXH. 23 - H&H CONSENT <TEXT> Document 5 - file: form8kamd101ex231-16.txt
</DOCUMENT> </SEC-DOCUMENT>